Astria Therapeutics won Food and Drug Administration orphan-drug designation for navenibart, its lead program candidate, for the treatment of the rare genetic disease hereditary angioedema.
A new approach to cancer treatment became available shortly before Jimmy Carter needed it. Now it's a pillar of care.
Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its ...
PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...
Your diet plays a significant role in managing cholesterol levels, and certain foods can significantly impact those numbers.
Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients ...
Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime Medicine to Generate Follow-on Candidates Rapidly and Efficiently -- -- ...
In reality, inflammation is a double-edged sword: It’s an ancient weapon that has enabled human bodies to fight off pathogens, poisons, and traumas for millennia, but it’s also a biological process ...